Ackermann DM, Dieng M, Medcalf E, et al. - Findings indicate the safety and feasibility of patient-led surveillance after treatment of localized melanoma. Also, this intervention was acceptable.

• This pilot randomized clinical trial included 100 patients who had received treatment for localized melanoma, had a smartphone, had a partner to assist with skin self-examination (SSE), and had been routinely attending scheduled follow-up visits.

• They were randomized to patient-led (n = 49) or clinician-led (n = 51) surveillance.

• Patient-led surveillance was linked with increased SSE frequency (odds ratio [OR], 3.5) and thoroughness (OR, 2.2), and had no detectable adverse impact on psychological outcomes, vs clinician-led surveillance.

• Also, patient-led surveillance increased clinic visits (risk ratio [RR], 1.5), skin lesion excisions (RR, 1.1), and subsequent melanoma diagnoses (risk difference, 10%), relative to clinician-led surveillance.

• Diagnosis of new primary melanomas and 1 local recurrence was made in 16% of the participants in the intervention group and in 6% of the participants in the control group.